Prophylaxis with palivizumab against respiratory syncytial virus infection in infants with congenital heart disease-who should receive it?
2008 ◽
Vol 23
(2)
◽
pp. 17-19
◽
1999 ◽
Vol 27
(9)
◽
pp. 1974-1981
◽
2011 ◽
Vol 54
(5)
◽
pp. 192
◽
2017 ◽
Vol 6
(1)
◽
pp. 37-56
◽
2018 ◽
Vol 195
◽
pp. 108-114.e1
◽
1988 ◽
Vol 30
(1)
◽
pp. 17-23
◽